
Computed tomography signs of pheochromocytomas and paragangliomas with different biochemical phenotypes: a comparative study
Zhao Xiaofang, Yang Ping, Liu Liu, Li Qingshu, Li Yi, Tao Fengming, Mao Yun
Computed tomography signs of pheochromocytomas and paragangliomas with different biochemical phenotypes: a comparative study
Objective To investigate whether the computed tomography(CT) signs of biochemically negative paragangliomas and pheochromocytomas (PPGLs) differ from those of biochemically positive PPGLs and whether there are differences in CT signs between different phenotypes of biochemically positive PPGLs. Methods A retrospective analysis was performed for the preoperative abdominal contrast-enhanced CT images of 131 patients with PPGLs,including tumor location,size,shape,cystic change and necrosis,fluid-fluid stratification,calcification,nodular centripetal enhancement,large blood vessels in tumor,enhancing capsule,absolute percentage washout,and relative percentage washout. According to biochemistry,the patients were divided into biochemically positive group and biochemically negative group,and the biochemically positive group was further divided into norepinephrine phenotype group,adrenaline phenotype group,and dopamine phenotype group. CT signs were compared between each group and different phenotypes. Results Compared with the biochemically negative group,the biochemically positive group had significantly larger PPGLs(Z=-2.064,P=0.039) and a significantly higher proportion of patients with cystic change and necrosis(χ2 =6.610,P=0.010) or nodular centripetal enhancement(χ2 =3.909,P=0.048),and compared with the norepinephrine phenotype group,the epinephrine phenotype group had significantly larger PPGLs(Z=-2.036,P=0.042) and a significantly higher proportion of patients with enhancing capsule(χ2 =7.242,P=0.007). Conclusion The CT signs of tumor size,cystic change and necrosis,and nodular centripetal enhancement can help with the diagnosis of biochemically negative PPGLs before surgery,and tumor size and enhancing capsule can help to explain the mechanism of different clinical manifestations of PPGLs with norepinephrine phenotype or epinephrine phenotype.
pheochromocytomas / paragangliomas / metanephrines / computed tomography / diagnosis
1 |
王庭俊,谢良地 .《嗜铬细胞瘤和副神经节瘤诊断治疗专家共识(2020版)》解读[J]. 中华高血压杂志,2021,29(8):708-714.
|
2 |
|
3 |
赵乃蕊,袁戈恒,张俊清. 488例肾上腺意外瘤住院患者临床特征及诊疗[J]. 重庆医科大学学报,2022,47(6):652-656.
|
4 |
|
5 |
|
6 |
|
7 |
|
8 |
|
9 |
|
10 |
|
11 |
|
12 |
|
13 |
|
14 |
|
15 |
|
16 |
|
17 |
|
18 |
王玲玲,马 茹,昌红,等. 肾上腺嗜铬细胞瘤的临床病理特征分析[J]. 临床肿瘤学杂志,2020,25(3):257-260.
|
/
〈 |
|
〉 |